[Form 4] Healthpeak Properties, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 shows that Healthpeak Properties, Inc. (symbol DOC) President & CEO Scott M. Brinker bought 2,873 common shares on 07/28/2025 at $17.40 each (transaction code “P”). After the purchase, Mr. Brinker directly owns 207,486 shares. No derivative securities were involved and no dispositions were reported.

• Role: President, CEO and Director
• Approximate cash outlay: ~$50k
• Filing made individually (not a joint filing)
• Power of Attorney on file (Exhibit 24)

Positive

• CEO open-market purchase suggests personal confidence and better alignment with shareholders.

Negative

• Very small dollar amount (≈$50k) limits the purchase’s materiality and market impact.

Insights

Securities Analyst

TL;DR: Small insider buy; mildly positive signal, but immaterial to fundamentals.

The CEO’s $50k open-market purchase marginally increases his stake, demonstrating personal confidence, yet the volume is insignificant versus both his existing holdings (now 207k shares) and Healthpeak’s 540m+ share count. With no sales or derivative activity, the transaction tilts sentiment positive, but it is unlikely to influence valuation or liquidity. Investors may view it as a token alignment gesture rather than a material commitment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Brinker Scott M

(Last) (First) (Middle)

4600 SOUTH SYRACUSE STREET

SUITE 500

(Street)

DENVER CO 80237

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HEALTHPEAK PROPERTIES, INC. [ DOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/28/2025		P		2,873	A	$17.4	207,486	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	Carol Samaan, SVP, Legal (Attorney-In-Fact)	07/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Healthpeak Properties (DOC) report in this Form 4?

CEO Scott M. Brinker bought 2,873 shares at $17.40 on 07/28/2025.

How many shares does the CEO own after the transaction?

He now directly owns 207,486 shares of Healthpeak Properties common stock.

Was this an open-market purchase or option exercise?

It was an open-market purchase, coded "P"—no options or derivatives involved.

Did the filing report any stock sales?

No. The Form 4 lists only the purchase; no dispositions were disclosed.

Is the transaction likely to be material to shareholders?

Given the small dollar value relative to the company’s market capitalization, the impact is considered immaterial.